Profile
Kyle Haraldsen currently works at Viridian Therapeutics, Inc., as Chief Technical Operations Officer from 2024.
Mr. Haraldsen also formerly worked at Lyndra Therapeutics, Inc., as Chief Technology Officer, AMAG Pharmaceuticals, Inc., as Vice President-Technical Operations, and Saniona AB, as Chief Technical Operations Officer.
Mr. Haraldsen received his undergraduate degree from Northeastern University.
Kyle Haraldsen active positions
| Companies | Position | Start |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2024 |
Former positions of Kyle Haraldsen
| Companies | Position | End |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Develops oral drug delivery platform | Chief Tech/Sci/R&D Officer | - |
| SANA AB | Corporate Officer/Principal | - |
Training of Kyle Haraldsen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Saniona AB
Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Develops oral drug delivery platform | Technology Services |
Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
- Stock Market
- Insiders
- Kyle Haraldsen
















